医药板块集体回调，恒生创新药ETF（159316）、生物科技ETF（159837）双双获资金逆势加码
Sou Hu Cai Jing·2025-11-04 09:58
Group 1 - The Hang Seng Hong Kong Stock Connect Innovative Drug Index decreased by 3.0% [1] - The CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index fell by 2.8% [1] - The CSI Innovative Drug Industry Index declined by 2.3% [1] Group 2 - The CSI Biotechnology Theme Index and the CSI 300 Pharmaceutical and Health Index both dropped by 1.8% [1] - Despite the market downturn, there was a significant net subscription for the Hang Seng Innovative Drug ETF (159316) and the Biotechnology ETF (159837), with net subscriptions reaching 44 million units and 40 million units respectively [1]